Screener
BOUT vs XUSP
Innovator IBD Breakout Opportunities ETF vs Innovator Uncapped Accelerated U.S. Equity ETF
Key differences
- Over the last 3 years, XUSP has delivered higher annualized returns.
Side-by-side comparison
| BOUT | XUSP | |
|---|---|---|
| Annual cost (TER) | 0.80% | 0.79% |
| Fund size (AUM) | $16M | $44M |
| Since | 2018 | 2022 |
| Dividend yield | 0.28% | 0.00% |
| Asset class | alternative | alternative |
| Region | north america | north america |
| Strategy | structured outcome | structured outcome |
| CAGR 1Y | +36.1% | +37.1% |
| CAGR 3Y | +17.0% | +25.9% |
| CAGR 5Y | +8.8% | N/A |
| Sharpe 3Y | 0.74 | 1.14 |
| Volatility 1Y | 20.75% | 15.98% |
| Max drawdown | -36.75% | -22.59% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to BOUT and XUSP
Explore further